-
The genomic landscape of lung adenocarcinoma in East Asians
Study
EGAS00001002941
-
Myeloma WGS
Study
EGAS00001004000
-
Colorectal adenomas, NKI-AvL TGO series Stool-Proteomics
Study
EGAS00001002953
-
Identification of Therapeutic Targets in Rhabdomyosarcoma Through Integrated Genomic, Epigenomic, and Proteomic Analyses
Study
EGAS00001002967
-
Integrated genomic analyses reveal molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
Study
EGAS00001005503
-
Whole-exome sequencing of intravascular large B-Cell lymphoma
Study
EGAS00001003970
-
Spiradenocarcinoma
Study
EGAS00001001799
-
The mutational landscape of primary central nervous system lymphoma (Hipo H050, A050, XD013)
Study
EGAS00001005339
-
Single cell exome sequencing of lung adenocarcinoma
Study
EGAS00001002972
-
WGS_of_healhy_mesothelial_cells_and_primary_mesothelima_cell_lines
Study
EGAS00001005559
-
Tumor-specific expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer
Study
EGAS00001004001
-
Host whole genome variations are associated with neurocognitive outcome in survivors of pediatric medulloblastoma
Study
EGAS00001002996
-
Germline elongator mutations in sonic hedgehog medulloblastoma
Study
EGAS00001004126
-
46 patients primary malignant glioma cohort in Chinese population
Study
EGAS00001005583
-
Multi-omics of Richter syndrome
Study
EGAS00001005495
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Cell type-specific transcriptomics of esophageal adenocarcinoma as a scalable alternative for single cell transcriptomics
Study
EGAS00001004053
-
Evolutionary dynamics of neuroblastoma
Study
EGAS00001004990
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Patient-derived neuroblastoma model system OHC-NB1
Study
EGAS00001003031
-
Sequence Data from the phase 2 PrE0505 trial of Durvalumab with First Line Platinum-Pemetrexed for Unresectable Pleural Mesothelioma
Study
EGAS00001005426
-
Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
Study
EGAS00001005437
-
Whole genome sequencing (bam files) of 5 samples of myxofibrosarcoma and 5 matched pairs
Study
EGAS00001005444
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__head___neck
Study
EGAS00001005450
-
MM samples for epigenomic translocation of H3K4me3 broad domains following super-enhancer hijacking
Study
EGAS00001005684